Literature DB >> 25884747

Common questions about the diagnosis and management of fibromyalgia.

Charles Kodner1.   

Abstract

Fibromyalgia has a distinct pathophysiology involving central amplification of peripheral sensory signals. Core symptoms are chronic widespread pain, fatigue, and sleep disturbance. Most patients with fibromyalgia have muscle pain and tenderness, forgetfulness or problems concentrating, and significant functional limitations. Fibromyalgia is diagnosed using an updated set of clinical criteria that no longer depend on tender point examination; laboratory testing may rule out other disorders that commonly present with fatigue, such as anemia and thyroid disease. Patients with fibromyalgia should be evaluated for comorbid functional pain syndromes and mood disorders. Management of fibromyalgia should include patient education, symptom relief, and regular aerobic physical activity. Serotoninnorepinephrine reuptake inhibitors, tricyclic antidepressants, antiepileptics, and muscle relaxants have the strongest evidence of benefit for improving pain, fatigue, sleep symptoms, and quality of life. Multiple complementary and alternative medicine therapies have been used but have limited evidence of effectiveness. Opioids should be used to relieve pain in carefully selected patients only if alternative therapies are ineffective.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25884747

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  4 in total

1.  Effectiveness and adverse effects of the use of mirtazapine as compared to duloxetine for fibromyalgia: real-life data from a retrospective cohort.

Authors:  Pankti Mehta; Amartya Basu; Sakir Ahmed
Journal:  Rheumatol Int       Date:  2022-04-27       Impact factor: 3.580

Review 2.  VOSviewer-Based Bibliometric Network Analysis for Evaluating Research on Juvenile Primary Fibromyalgia Syndrome (JPFS).

Authors:  Alessandro Vittori; Marco Cascella; Marianna Leonardi; Federica Monaco; Davide Nocerino; Arturo Cuomo; Alessandro Ottaiano; Francesco Perri; Ilaria Mascilini; Elisa Francia; Emiliano Petrucci; Franco Marinangeli; Sergio Giuseppe Picardo
Journal:  Children (Basel)       Date:  2022-04-28

3.  Excess use of thyroid hormone treatment among patients with fibromyalgia: a cross-sectional study in primary health care.

Authors:  Varinen Aleksi; Kosunen Elise; Tuomas H Koskela
Journal:  BMC Res Notes       Date:  2022-02-24

4.  Depression: A Modifiable Risk Factor for Poor Outcomes in Fibromyalgia.

Authors:  Bala Munipalli; Madeleine E Allman; Mohit Chauhan; Shehzad K Niazi; Fernando Rivera; Andy Abril; Benjamin Wang; Mikolaj A Wieczorek; David O Hodge; Dacre Knight; Adam Perlman; Abd Moain Abu Dabrh; Daniel Dudenkov; Barbara K Bruce
Journal:  J Prim Care Community Health       Date:  2022 Jan-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.